Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda set to move from Deerfield Illinois, 1000 jobs affected

September 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois

Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …

News
john_nason

Teva names new President, TAPI and Biologics Operations

September 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment

Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …

Appointment
shutterstock_159488225

Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer

September 12, 2018
Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma

Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …

News

BMS’ investigational psoriasis drug hits primary endpoint in skin clearance at Phase 2

September 12, 2018
Research and Development BMS, BMS-986165, Bristol-Myers Squibb, pharma, psoriasis

Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as …

News
injection

More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter

September 12, 2018
Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …

News
14680814113_e81affc144_z_1

UK Health Secretary Matt Hancock rallies against ‘rip off’ pharma companies

September 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Matt Hancock, NICE, Vertex, pharma, pricing

British Health Secretary Matt Hancock has said that pharmaceutical companies are trying to “rip off taxpayers” and that big business …

News

Protesters in Manchester call on NICE to approve Biogen’s $750,000 drug Spinraza

September 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Spinraza, approval, protest, sma

Protesters in Manchester have called on the National Institute of Health and Care Excellence (NICE), to overturn their rejection of …

News
s712_phe_sign_960x640

UK health improving but challenges of an ageing population remain, says PHE report

September 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Public Health England, UK, pharma

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the …

News
d2644e613f

Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland

September 11, 2018
Manufacturing and Production Alcon, Novartis, eye care, pharma

Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …

News
6127243966_e9189f1099_z

PhRMA blames hospitals for rising drug prices, hospitals association responds

September 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Drug pricing, PhRMA, hospitals, pharma

The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the …

News

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …

News

Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …

News
drug_safety

Drug safety: UK and EU post-Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

Feature
opdivo_1_1

BMS’ Opdivo fails to win over NICE as adjuvant melanoma therapy

September 10, 2018
Sales and Marketing BMS, NHS, NICE, melanoma, opdivo, pharma

Bristol-Myers Squibb has failed to convince NICE to approve the use of its PD-1 inhibitor immunotherapy Opdivo (nivolumab) as an …

News
merckentranceweb

Keytruda scores ground-breaking European approval in lung cancer subgroup

September 10, 2018
Sales and Marketing Cancer, EU, Europe, MSD, Merck, NSCLC, keytruda, lung cancer, pharma

Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based …

News

GSK’s Nucala data insufficient for US COPD approval

September 10, 2018
Sales and Marketing COPD, FDA, GSK, Nucala, US, pharma

GlaxoSmithKline has suffered a regulatory blow in the label expansion of its interleukin-5 (IL5) inhibitor Nucala (mepolizumab), with the FDA …

News

Akcea cuts 10% of staff following FDA rejection

September 10, 2018
Manufacturing and Production, Sales and Marketing Akcea, FDA, Waylivra, pharma

Akcea Therapeutics has been hit hard by the FDA’s decision to reject its drug Waylivra (volanesorsen) for the treatment of …

News

NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis

September 10, 2018
Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma

Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …

News
nhs_sign

UK Government to invest £200m in IT and technology boost for NHS

September 7, 2018
Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma

The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026